COVID-19 pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with haematological malignancy: A single-centre experience

被引：0
|
作者：
Lee, Kee Tat [1 ]
Low, Woei Chyuan [1 ]
Tan, Sui Keat [1 ]
Chiang, Su Kien [1 ]
Chew, Teng Keat [1 ]
Goh, Ai Sim [1 ]
机构：
[1] Hosp Pulau Pinang, Hematol, Georgetown, Malaysia
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH23-EP51
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [31] Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab (evusheld) in patients with multiple myeloma in the omicron SARS-COV-2 era
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Eleutherakis-Papaiakovou, Evangelos
    Malandrakis, Panagiotis
    Spiliopoulou, Vassiliki
    Syrigou, Rodanthi-Eleni
    Theodorakakou, Foteini
    Fotiou, Despina
    Migkou, Magdalini
    Roussou, Maria
    Kastritis, Efstathios
    Dimopoulos, Meletios
    Terpos, Evangelos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S302 - S303
  • [32] Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
    Ivo Demel
    David Skopal
    Eliška Šafránková
    Petra Rozsívalová
    Pavel Jindra
    Jiří Šrámek
    Adéla Turková
    Jan Vydra
    Klára Labská
    Jana Vedrová
    Martin Čerňan
    Tomáš Szotkowski
    Heidi Móciková
    Lenka Hynková
    Ondrej Šušol
    Ingrid Kováčová
    David Belada
    Roman Hájek
    Annals of Hematology, 2024, 103 : 981 - 992
  • [33] SARS-COV-2 Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab in Haematological, Immunocompromised Patients in the Omicron Era
    Hoechstetter, Manuela A.
    Hollwich, Eva-Maria
    Illner, Doris
    Pham, Thu-Trang
    von Bergwelt-Baildon, Michael
    Dreyling, Martin
    Wendtner, Clemens-Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 690 - 699
  • [34] Risk factors for breakthrough COVID-19 infections in solid organ transplant recipients receiving tixagevimab/cilgavimab for pre-exposure prophylaxis
    Abraham, Dana L.
    Lichvar, Alicia B.
    Brubaker, Aleah L.
    Haste, Nina
    Chen, Victor
    Abeles, Shira
    Aslam, Saima
    Yam, Nancy
    Horton, Lucy
    Chen, Benjamin
    Binkin, Nancy
    Law, Nancy
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [35] Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan
    Taniguchi, Toshibumi
    Homma, Tomoyuki
    Tamai, Yoichi
    Arita, Yoshifumi
    Fujiwara, Masakazu
    Kuroishi, Naho
    Sugiyama, Keiji
    Kanazu, Shinichi
    Maruyama, Atsushi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (01)
  • [36] Risk Factors for Breakthrough Covid-19 Infections in Solid Organ Transplant Recipients Receiving Tixagevimab/cilgavimab for Pre-Exposure Prophylaxis
    Abraham, D.
    Lichvar, A.
    Haste, N.
    Chen, V.
    Abeles, S.
    Aslam, S.
    Binkin, N.
    Yam, N.
    Horton, L.
    Chen, B.
    Brubaker, A.
    Law, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S655 - S655
  • [37] COST-EFFECTIVENESS OF AZD7442 (TIXAGEVIMAB AND CILGAVIMAB) FOR PRE-EXPOSURE PROPHYLAXIS AGAINST COVID-19 IN THE IMMUNOCOMPROMISED POPULATION
    Sutton, K.
    Miller, P.
    Branscombe, N.
    Mittal, M.
    Browne, C.
    Arnetorp, S.
    Henry, T.
    Breslin, K.
    Bungey, G.
    Quint, J.
    Montgomery, H.
    VALUE IN HEALTH, 2022, 25 (12) : S168 - S168
  • [38] Incidence of breakthrough COVID-19 in patients with hematological disorders who received pre-exposure prophylaxis with tixagevimab-cilgavimab: a retrospective study in Japan
    Mizuki Haraguchi
    Hisashi Yamamoto
    Otoya Watanabe
    Takashi Sakoh
    Keiko Ishida
    Sho Ogura
    Masayo Katoh-Morishima
    Yuki Taya
    Aya Nishida
    Daisuke Kaji
    Shinsuke Takagi
    Go Yamamoto
    Naoyuki Uchida
    Hideki Araoka
    Bone Marrow Transplantation, 2023, 58 : 1051 - 1053
  • [39] Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
    Sindu, Devika
    Razia, Deepika
    Grief, Katherine
    Cherrier, Lauren
    Omar, Ashraf
    Walia, Rajat
    Tokman, Sofya
    TRANSPLANTATION DIRECT, 2023, 9 (06): : E1485
  • [40] Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
    Vergori, Alessandra
    Matusali, Giulia
    Cimini, Eleonora
    Bordi, Licia
    Borrelli, Paola
    Lanini, Simone
    Palazzi, Roberta
    Paulicelli, Jessica
    Mariotti, Davide
    Mazzotta, Valentina
    Notari, Stefania
    Casetti, Rita
    Francalancia, Massimo
    Rosati, Silvia
    D'Abramo, Alessandra
    Mija, Cosmina
    Mencarini, Paola
    Milozzi, Eugenia
    Caraffa, Emanuela
    Sica, Simona
    Metafuni, Elisabetta
    Sora, Federica
    Rago, Angela
    Siniscalchi, Agostina
    Abruzzese, Elisabetta
    Garzia, Mariagrazia
    Luzi, Giovanni
    Battistini, Roberta
    Prosperini, Luca
    Cingolani, Antonella
    Girardi, Enrico
    Maggi, Fabrizio
    Antinori, Andrea
    VACCINES, 2024, 12 (07)
12345